Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (DHEA) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy

• 收藏
• 分享

专利权人:

Inc.;Endorecherche

发明人:

Labrie, Fernand

申请号：

AU2013296091

公开号：

AU2013296091A1

申请日:

2013.07.19

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

Intravaginal DHEA is used for the treatment of at least one condition selected from the group consisting of female hypoactive sexual desire disorder, female sexual arousal disorder, female orgasm disorder and female sexual interest arousal disorder in a woman who either (1) is not suffering from symptoms of vulvo-vaginal atrophy and/or (2) is not suffering from moderate to severe dyspareunia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/